パチスロ 麻雀 物語 3 News

パチスロ 麻雀 物語 3 "MUCODYNE® DS50%"

January 18, 2010

KYORIN Pharmaceutical パチスロ 麻雀 物語 3., Ltd. (Headquarter: Tokyo, President: Keiji Hirai), a subsidiary of KYORIN パチスロ 麻雀 物語 3., Ltd. announced today that the Ministry of Health, Labour and Welfare approved "MUCODYNE® DS50%" (INN: L-Carbocisteine), Mucoregulating drug, on January 15, 2010.

Please see the PDF file below for details.